Research Output per year
Fingerprint Dive into the research topics where Elisabetta Vergani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Melanoma
Medicine & Life Sciences
MicroRNAs
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
TNF-Related Apoptosis-Inducing Ligand
Medicine & Life Sciences
Tumor Microenvironment
Medicine & Life Sciences
Exosomes
Medicine & Life Sciences
Immunosuppressive Agents
Medicine & Life Sciences
Immunotherapy
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2016 2019
5
Citations
(Scopus)
Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy
Tuccitto, A., Shahaj, E., Vergani, E., Ferro, S., Huber, V., Rodolfo, M., Castelli, C., Rivoltini, L. & Vallacchi, V., Apr 1 2019, In : Virchows Archiv. 474, 4, p. 407-420 14 p.Research output: Contribution to journal › Review article
Tumor Microenvironment
Immunosuppressive Agents
Neoplasms
Adaptive Immunity
Immunosuppression
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
Huber, V., Vallacchi, V., Fleming, V., Hu, X., Cova, A., Dugo, M., Shahaj, E., Sulsenti, R., Vergani, E., Filipazzi, P., De Laurentiis, A., Lalli, L., Di Guardo, L., Patuzzo, R., Vergani, B., Casiraghi, E., Cossa, M., Gualeni, A., Bollati, V., Arienti, F. & 7 others, , Dec 3 2018, In : Journal of Clinical Investigation. 128, 12, p. 5505-5516 12 p.Research output: Contribution to journal › Article
Myeloid Cells
MicroRNAs
Immunotherapy
Melanoma
Neoplasms
4
Citations
(Scopus)
MicroRNA expression in sentinel nodes fromprogressing melanoma patients identifies networks associated with dysfunctional immune response
Vallacchi, V., Camisaschi, C., Dugo, M., Vergani, E., Deho, P., Gualeni, A. V., Huber, V., Gloghini, A., Maurichi, A., Santinami, M., Sensi, M., Castelli, C., Rivoltini, L. & Rodolfo, M., Dec 14 2016, In : Genes. 7, 12, 124.Research output: Contribution to journal › Article
MicroRNAs
Melanoma
Biopsy
Biomarkers
Neoplasms
32
Citations
(Scopus)
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
Vergani, E., Di Guardo, L., Dugo, M., Rigoletto, S., Tragni, G., Ruggeri, R., Perrone, F., Tamborini, E., Gloghini, A., Arienti, F., Vergani, B., Deho, P., De Cecco, L., Vallacchi, V., Frati, P., Shahaj, E., Villa, A., Santinami, M., De Braud, F., Rivoltini, L. & 1 others, , 2016, In : Oncotarget. 7, 4, p. 4428-4441 14 p.Research output: Contribution to journal › Article
Melanoma
MicroRNAs
Apoptosis
Cell Proliferation
Cell Line
Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer
Camisaschi, C., Vallacchi, V., Vergani, E., Tazzari, M., Ferro, S., Tuccitto, A., Kuchuk, O., Shahaj, E., Sulsenti, R., Castelli, C., Rodolfo, M., Rivoltini, L. & Huber, V., Nov 4 2016, In : Vaccines. 4, 4Research output: Contribution to journal › Article
Neoplasms
Tumor Microenvironment
Immunosuppressive Agents
Immunotherapy
Immunity